Charles Cotropia

Charles Cotropia

Corporate Officer/Principal en
State Bar of Texas
.
Commercial Services
Consumer Services
Health Technology

Perfil

Charles S.
Cotropia
was the founder of Bioclonetics Immunotherapeutics, Inc. (founded in 2009) where he served as the Chief Executive Officer & Director from 2009 to 2020.
He is currently the President & Director at Biogenysis, Inc. and a Member of the State Bar of Texas.
Previously, he was the President, Chief Executive Officer & Director at Enzolytics, Inc. from 2020 to 2024.
He also held the position of Director at the Dallas Bar Association.
Prior to that, he worked as Senior Counsel at Sidley Austin LLP from 1973 to 2015.
Mr. Cotropia obtained his undergraduate degree from The University of Texas at Austin and his graduate degree from Cornell University.

Cargos activos de Charles Cotropia

EmpresasCargoInicio
Corporate Officer/Principal -

Antiguos cargos conocidos de Charles Cotropia.

EmpresasCargoFin
ENZOLYTICS, INC. Director Ejecutivo 19/03/2024
Presidente 23/02/2024
Fundador 01/12/2020
Consejero General 01/01/2015
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Charles Cotropia.

Formación de Charles Cotropia.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

100 +

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

  1. Bolsa de valores
  2. Insiders
  3. Charles Cotropia
-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN